3 French Catheter Expands Vaxcel® PICC with PASV® Product Line
The 3 French catheter expands the application of PASV (Pressure Activated Safety Valve) Technology, particularly in pediatric and elderly patient populations who tend to have smaller vein access.
Navilyst Medical's catheters with proprietary PASV Valve Technology have been shown to reduce rates of catheter occlusions (blockages) and catheter-related bloodstream infections. Effective October 1, 2008, U.S. hospitals are now cost accountable for certain medical errors and preventable medical care complications, including catheter-related bloodstream infections. At an estimated $100,000 per event which includes increased diagnostic and therapeutic costs, and increased length of hospitalization, reducing the rate of hospital acquired catheter-related infections has become a top priority for hospital administrators and hospital infection control teams nationwide.